Literature DB >> 20493416

Rheumatoid pneumoconiosis (Caplan's syndrome).

J Schreiber1, D Koschel, J Kekow, N Waldburg, A Goette, R Merget.   

Abstract

In 1953, Caplan described a characteristic radiographic pattern in coal miners with rheumatoid arthritis (RA) that was distinct from the typical progressive massive fibrosis pattern of coalworkers' pneumoconiosis. It consists of multiple well-defined rounded nodules on chest X-ray, from about 0.5 to about several centimetres in diameter, distributed throughout the lungs but predominantly at the lung periphery. Lesions appear often in crops, may coalesce and form a larger confluent nodule. Nodules often cavitate or calcify. They typically occur in the setting of pre-existing mild pneumoconiosis, but pneumoconiosis is not a prerequisite. The onset of the nodules is typically sudden, and their course varies thereafter, ranging from regression to progression. Histologically, the nodules have a characteristic appearance and are distinguishable from silicotic nodules or progressive massive fibrosis. Individual susceptibility is considered to play a role in the development of the disease. However, the pathogenetic link between exposure to silica, pneumoconiosis and RA has not been clarified conclusively. This review summarizes history, definition and current knowledge on epidemiology, pathology, pathophysiology, clinical presentation and treatment of Caplan's syndrome. Copyright 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20493416     DOI: 10.1016/j.ejim.2010.02.004

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  13 in total

Review 1.  Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications.

Authors:  Thanissara Chansakul; Paul F Dellaripa; Tracy J Doyle; Rachna Madan
Journal:  Eur J Radiol       Date:  2015-07-17       Impact factor: 3.528

2.  What to do with all of these lung nodules?

Authors:  Dmitry Rozenberg; Shane Shapera
Journal:  Can Respir J       Date:  2014 May-Jun       Impact factor: 2.409

Review 3.  Respiratory diseases caused by coal mine dust.

Authors:  A Scott Laney; David N Weissman
Journal:  J Occup Environ Med       Date:  2014-10       Impact factor: 2.162

4.  Caplan's Syndrome with a twist.

Authors:  Janaki Deepak; Blaine Kenaa
Journal:  Int J Clin Case Rep Rev       Date:  2020-01-22

Review 5.  Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis.

Authors:  Hidenori Matsuzaki; Megumi Maeda; Suni Lee; Yasumitsu Nishimura; Naoko Kumagai-Takei; Hiroaki Hayashi; Shoko Yamamoto; Tamayo Hatayama; Yoko Kojima; Rika Tabata; Takumi Kishimoto; Junichi Hiratsuka; Takemi Otsuki
Journal:  J Biomed Biotechnol       Date:  2012-02-06

Review 6.  Asbestos induces reduction of tumor immunity.

Authors:  Naoko Kumagai-Takei; Megumi Maeda; Ying Chen; Hidenori Matsuzaki; Suni Lee; Yasumitsu Nishimura; Junichi Hiratsuka; Takemi Otsuki
Journal:  Clin Dev Immunol       Date:  2011-10-04

7.  A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients.

Authors:  Jun-Xiang Wang; Chuan-Guo Du
Journal:  Med Sci Monit       Date:  2015-03-07

Review 8.  The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Authors:  Lorenzo Cavagna; Sara Monti; Vittorio Grosso; Nicola Boffini; Eva Scorletti; Gloria Crepaldi; Roberto Caporali
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

9.  Silicon, a Possible Link between Environmental Exposure and Autoimmune Diseases: The Case of Rheumatoid Arthritis.

Authors:  Cesar A Speck-Hernandez; Gladis Montoya-Ortiz
Journal:  Arthritis       Date:  2012-10-18

Review 10.  Thoracic Manifestations of Rheumatoid Arthritis.

Authors:  Anthony J Esposito; Sarah G Chu; Rachna Madan; Tracy J Doyle; Paul F Dellaripa
Journal:  Clin Chest Med       Date:  2019-07-06       Impact factor: 4.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.